These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1120 related items for PubMed ID: 7878241

  • 1. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F, Castrucci M, Sironi S, Livraghi T, Venturini M, Salvioni M, Del Maschio A.
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [Abstract] [Full Text] [Related]

  • 2. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].
    Liu R, Wang JH, Zhou KR, Yan FH, Yan ZP, Shen JZ, Tan YS, Cai Y.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):754-8. PubMed ID: 16248948
    [Abstract] [Full Text] [Related]

  • 3. Small hepatocellular carcinoma: MR follow-up of treatment with percutaneous ethanol injection.
    Sironi S, Livraghi T, Angeli E, Vanzulli A, Villa G, Colombo E, Taccagni G, DelMaschio A.
    Radiology; 1993 Apr; 187(1):119-23. PubMed ID: 8383864
    [Abstract] [Full Text] [Related]

  • 4. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
    Bartolozzi C, Lencioni R, Caramella D, Mazzeo S, Ciancia EM.
    AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000
    [Abstract] [Full Text] [Related]

  • 5. Plain and gadolinium-DTPA-enhanced MR imaging of hepatocellular carcinoma treated with transarterial chemoembolization.
    Castrucci M, Sironi S, De Cobelli F, Salvioni M, Del Maschio A.
    Abdom Imaging; 1996 Apr; 21(6):488-94. PubMed ID: 8875869
    [Abstract] [Full Text] [Related]

  • 6. Percutaneous ethanol injection therapy for hepatocellular carcinoma: validity of MR imaging in the evaluation of treatment effect.
    Usui H, Itai Y.
    Radiat Med; 1995 Apr; 13(3):103-8. PubMed ID: 7569000
    [Abstract] [Full Text] [Related]

  • 7. Small hepatocellular carcinoma treated with percutaneous ethanol injection: unenhanced and gadolinium-enhanced MR imaging follow-up.
    Sironi S, De Cobelli F, Livraghi T, Villa G, Zanello A, Taccagni G, DelMaschio A.
    Radiology; 1994 Aug; 192(2):407-12. PubMed ID: 8029405
    [Abstract] [Full Text] [Related]

  • 8. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC, Fauda V, Scaramuzza D, Vergnaghi D.
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [Abstract] [Full Text] [Related]

  • 9. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?
    Goshima S, Kanematsu M, Kondo H, Yokoyama R, Tsuge Y, Shiratori Y, Onozuka M, Moriyama N.
    J Magn Reson Imaging; 2008 Apr; 27(4):834-9. PubMed ID: 18383261
    [Abstract] [Full Text] [Related]

  • 10. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
    Kamel IR, Bluemke DA, Eng J, Liapi E, Messersmith W, Reyes DK, Geschwind JF.
    J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675
    [Abstract] [Full Text] [Related]

  • 11. [Combined treatment of hepatocarcinoma with chemoembolization and alcohol administration. Long-term results].
    Bartolozzi C, Lencioni R, Armillotta N.
    Radiol Med; 1997 Mar; 94(1-2):19-23. PubMed ID: 9424645
    [Abstract] [Full Text] [Related]

  • 12. Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography.
    Kim SH, Lee WJ, Lim HK, Lim JH.
    J Comput Assist Tomogr; 2007 Mar; 31(2):198-203. PubMed ID: 17414753
    [Abstract] [Full Text] [Related]

  • 13. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A, Bitsch RG, Schemmer P, Grenacher L, Düx M, Kauffmann GW.
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [Abstract] [Full Text] [Related]

  • 14. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK, Wikström M, Flechtenmacher C, Filser T, Dueber C.
    Cardiovasc Intervent Radiol; 2006 Dec; 29(5):778-84. PubMed ID: 16779690
    [Abstract] [Full Text] [Related]

  • 15. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
    Chen XM, Luo PF, Lin HH, Zhou ZJ, Shao PJ, Fu L, Li WK.
    Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
    [Abstract] [Full Text] [Related]

  • 16. Small hyperintense hepatic lesions on T1-weighted images in patients with cirrhosis: evaluation with serial MRI and imaging features for clinical benignity.
    Shimizu A, Ito K, Sasaki K, Hayashida M, Tanabe M, Shimizu K, Matsunaga N.
    Magn Reson Imaging; 2007 Dec; 25(10):1430-6. PubMed ID: 17524587
    [Abstract] [Full Text] [Related]

  • 17. Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization.
    Vossen JA, Kamel IR, Buijs M, Liapi E, Georgiades CS, Hong K, Geschwind JF.
    J Comput Assist Tomogr; 2008 Dec; 32(3):347-52. PubMed ID: 18520535
    [Abstract] [Full Text] [Related]

  • 18. Imaging of benign hypervascular hepatocellular nodules in alcoholic liver cirrhosis: differentiation from hypervascular hepatocellular carcinoma.
    Kobayashi S, Matsui O, Kamura T, Yamamoto S, Yoneda N, Gabata T, Terayama N, Sanada J.
    J Comput Assist Tomogr; 2007 Dec; 31(4):557-63. PubMed ID: 17882031
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases].
    Fan WJ, Zhang L, Ouyang YS.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 16; 88(35):2474-7. PubMed ID: 19080627
    [Abstract] [Full Text] [Related]

  • 20. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
    Buijs M, Kamel IR, Vossen JA, Georgiades CS, Hong K, Geschwind JF.
    J Vasc Interv Radiol; 2007 Aug 16; 18(8):957-63. PubMed ID: 17675611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.